We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
-4.69%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
-$972M
(-6.2%)
Cap. Flow
+$106M
Cap. Flow
% of AUM
0.72%
Top 10 Holdings %
Top 10 Hldgs %
23.63%
Holding
875
New
75
Increased
357
Reduced
296
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$90.2M |
| 2 |
Merck
MRK
|
+$70M |
| 3 |
Adobe
ADBE
|
+$55.1M |
| 4 |
Booking.com
BKNG
|
+$34.5M |
| 5 |
ServiceNow
NOW
|
+$30.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$51.3M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$40.4M |
| 3 |
Salesforce
CRM
|
+$36.7M |
| 4 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$36.4M |
| 5 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$30.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.35% |
| 2 | Technology | 26.36% |
| 3 | Financials | 8.78% |
| 4 | Communication Services | 7.85% |
| 5 | Consumer Discretionary | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Trane Technologies
TT
$98.8B
| $3K | ﹤0.01% |
+18
| New | +$2.94K |
|
752
Equinor
EQNR
$97.3B
| $2K | ﹤0.01% |
+52
| New | +$1.62K |
|
|
NVO
753
Novo Nordisk
NVO
$228B
| $2K | ﹤0.01% |
+42
| New | +$2.16K |
|
754
Rio Tinto
RIO
$152B
| $2K | ﹤0.01% |
+29
| New | +$2.2K |
|
|
TEF
755
DELISTED
Telefonica
TEF
| $2K | ﹤0.01% |
+382
| New | +$1.7K |
|
756
TotalEnergies
TTE
$193B
| $2K | ﹤0.01% |
+44
| New | +$2.38K |
|
757
Vodafone
VOD
$37.1B
| $2K | ﹤0.01% |
+91
| New | +$1.55K |
|
758
AGNC Investment
AGNC
$12.7B
| $1K | ﹤0.01% |
+79
| New | +$1.1K |
|
759
Allegion
ALLE
$13.5B
| $1K | ﹤0.01% |
+11
| New | +$1.3K |
|
760
BP
BP
$112B
| $1K | ﹤0.01% |
+48
| New | +$1.46K |
|
761
ORIX
IX
$42.7B
| $1K | ﹤0.01% |
+65
| New | +$1.33K |
|
|
MRUS
762
DELISTED
Merus
MRUS
| $1K | ﹤0.01% |
+49
| New | +$1.31K |
|
763
Qiagen
QGEN
$8.62B
| $1K | ﹤0.01% |
+10
| New | +$516 |
|
764
Banco Santander
SAN
$191B
| $1K | ﹤0.01% |
+361
| New | +$1.26K |
|
765
Sanofi
SNY
$107B
| $1K | ﹤0.01% |
+23
| New | +$1.19K |
|
766
Takeda Pharmaceutical
TAK
$56.7B
| $1K | ﹤0.01% |
+82
| New | +$1.2K |
|
767
TE Connectivity
TEL
$60B
| $1K | ﹤0.01% |
+10
| New | +$1.43K |
|
768
Arch Capital
ACGL
$35.7B
| – | – |
-15,491
| Closed | -$689K |
|
|
AKRO
769
DELISTED
Akero Therapeutics
AKRO
| – | – |
-88,876
| Closed | -$1.88M |
|
770
Aldeyra Therapeutics
ALDX
$97.1M
| – | – |
-140,000
| Closed | -$560K |
|
771
Digital Turbine
APPS
$982M
| – | – |
-5,000
| Closed | -$305K |
|
772
Assembly Biosciences
ASMB
$498M
| – | – |
-153,185
| Closed | -$4.28M |
|
773
BlackBerry
BB
$4.58B
| – | – |
-20,650
| Closed | -$193K |
|
774
Cable One
CABO
$237M
| – | – |
-116
| Closed | -$205K |
|
775
Chunghwa Telecom
CHT
$33.5B
| – | – |
-9,483
| Closed | -$400K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q1 2022 Portfolio in Review
As of Q1 2022, Candriam SCA held 875 positions worth $14.7B, down 6.2% from $15.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Candriam SCA's Q1 2022 filing shows 75 new, 357 increased, 296 reduced and 67 closed positions. Its largest new stake was Ecopetrol: 1,389,000 shares worth $25.8M. The largest sale was Amgen, an estimated $51.3M.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 31% a quarter earlier, followed by Technology and Financials.
- Candriam SCA's largest Q1 2022 buy was Ecopetrol: 1,389,000 shares worth $25.8M.
- Candriam SCA added most to Walt Disney in Q1 2022, an estimated $90.2M increase.
- Candriam SCA's biggest Q1 2022 reduction was Amgen, cutting an estimated $51.3M.
- Candriam SCA fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $36.4M.
- Candriam SCA's ten largest holdings make up 24% of its $14.7B portfolio in Q1 2022.
- Candriam SCA opened 75 new positions and closed 67 in Q1 2022.
- Candriam SCA's portfolio value fell 6.2% quarter-over-quarter to $14.7B.
Based on Candriam SCA's 13F filing for Q1 2022, filed 13 May 2022.